Identification of human cancers deficient in antigen processing

Area of Science:

• Immunology
• Cancer Biology
• Molecular Biology

Background:

• Intracellular antigen processing and presentation via Major Histocompatibility Complex (MHC) class I molecules are crucial for CD8+ T cell recognition.
• Tumors may employ immune evasion strategies, including impaired antigen processing, to escape immune surveillance.

Purpose of the Study:

• To investigate the antigen processing efficiency of human tumor cell lines.
• To identify the molecular mechanisms underlying defects in antigen processing in specific tumor types.
• To explore potential therapeutic interventions to restore antigen processing in tumors.

Main Methods:

• Utilized recombinant vaccinia virus to express the Kd molecule for antigen presentation studies.
• Assessed antigen processing in 26 human tumor lines.
• Employed pulse-chase experiments to track MHC class I molecule transport.
• Conducted Northern blot analysis to quantify mRNA levels of proteasome and peptide transporter components.
• Treated cells with interferon gamma to evaluate its effect on gene expression and antigen processing.

Main Results:

• Three small cell lung carcinoma lines failed to process endogenous antigens for presentation to T cells.
• These cell lines exhibited impaired transport of MHC class I molecules from the endoplasmic reticulum to the cell surface.
• Low mRNA levels for proteasome components (LMP-7, LMP-2) and peptide transporters (TAP-1, TAP-2) were observed.
• Interferon gamma treatment restored mRNA expression and corrected the functional and biochemical deficits.

Conclusions:

• Downregulation of antigen processing, specifically reduced expression of MHC-encoded proteasome and transporter genes, is a potential immune evasion strategy used by tumors.
• Restoring the expression of these genes, for example, through interferon gamma, could be a therapeutic approach to enhance anti-tumor immunity.